Sodium-glucose cotransporter-2 inhibitors for improving endocrine and metabolic profiles in overweight and obese individuals with polycystic ovary syndrome: a meta-analysis protocol

INTRODUCTION: Polycystic ovary syndrome (PCOS) is a heterogeneous reproductive endocrine disorder. Several ongoing trials test sodium-glucose cotransporter-2 (SGLT-2) inhibitors for women with PCOS. However, their effectiveness has not been fully elucidated owing to the lack of high-confidence evide...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jiaqi, Xing, Chuan, He, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Diabetes and Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039375/
https://www.ncbi.nlm.nih.gov/pubmed/35470198
http://dx.doi.org/10.1136/bmjopen-2021-058260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9039375/
https://www.ncbi.nlm.nih.gov/pubmed/35470198
http://dx.doi.org/10.1136/bmjopen-2021-058260

Ejemplares similares